THE EFFECT OF GV1001, A PEPTIDE VACCINE, IN ANIMAL MODEL OF RHEUMATOID ARTHRITIS

被引：1
|
作者：
Choi, I. A. [1 ]
Choi, J-Y. [2 ]
Jung, S. [3 ]
Basri, F. [3 ]
Park, S. [3 ]
Lee, E. Y. [2 ]
机构：
[1] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Cheongju, South Korea
[2] Seoul Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Seoul, South Korea
[3] Korea Univ, Dept Life Sci, Seoul, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.5312
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0122
引用
收藏
页码：931 / 931
页数：1
相关论文
共 50 条
  • [21] Drug evaluation: GV-1001, an injectable telomerase peptide vaccine for the treatment of solid cancers
    Nava-Parada, Pilar
    Emens, Leisha A.
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2007, 9 (05) : 490 - 497
  • [22] Telomerase-specific GV1001 peptide vaccination fails to induce objective tumor response in patients with cutaneous T cell lymphoma
    Schlapbach, Christoph
    Yerly, Daniel
    Daubner, Barbara
    Yawalkar, Nikhil
    Hunger, Robert E.
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2011, 62 (02) : 75 - 83
  • [23] GV1001, hTERT Peptide Fragment, Prevents Doxorubicin-Induced Endothelial-to-Mesenchymal Transition in Human Endothelial Cells and Atherosclerosis in Mice
    Chen, Wei
    Kim, Seojin
    Kim, Sharon Y.
    Beheshtian, Cheyenne
    Kim, Naryung
    Shin, Ki-Hyuk
    Kim, Reuben H.
    Kim, Sangjae
    Park, No-Hee
    CELLS, 2025, 14 (02)
  • [24] The Effect of Human Placental Extract on Rheumatoid Arthritis in an Animal Model
    Park, Jeong Dong
    Lee, Sang-Il
    Kim, A. Ram
    Park, Jong Moon
    Shin, Sang-Yeop
    Shin, Jun Hwa
    Moon, Seung Won
    Park, Hyun
    Oh, Min-Kyun
    Shin, Hee Suk
    ANNALS OF REHABILITATION MEDICINE-ARM, 2012, 36 (02): : 197 - 206
  • [25] The Effect of Ozone on Bone Strenght in Animal Model of Rheumatoid Arthritis
    Bozbas, Gulnur Tasci
    Kilimci, Figen Sevil
    Yilmaz, Mustafa
    Gurer, Gulcan
    Demirci, Buket
    TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS, 2016, 22 (02): : 74 - 79
  • [26] GV1001 reduces neurodegeneration and prolongs lifespan in 3xTg-AD mouse model through anti-aging effects
    Park, Hyun-Hee
    Kwon, Hyuk Sung
    Lee, Kyu-Yong
    Kim, Ye Eun
    Son, Jeong-Woo
    Choi, Na-Young
    Han, Myung-Hoon
    Park, Dong Woo
    Kim, Sangjae
    Koh, Seong-Ho
    AGING-US, 2024, 16 (03): : 1983 - 2004
  • [27] Neural stem cells injured by oxidative stress can be rejuvenated by GV1001, a novel peptide, through scavenging free radicals and enhancing survival signals
    Park, Hyun-Hee
    Yu, Hyun-Jung
    Kim, Sangjae
    Kim, Gabseok
    Choi, Na-Young
    Lee, Eun-Hye
    Lee, Young Joo
    Yoon, Moon-Young
    Lee, Kyu-Yong
    Koh, Seong-Ho
    NEUROTOXICOLOGY, 2016, 55 : 131 - 141
  • [28] hTERT Peptide Fragment GV1001 Prevents the Development of Porphyromonas gingivalis-Induced Periodontal Disease and Systemic Disorders in ApoE-Deficient Mice
    Chen, Wei
    Kim, Sharon Y.
    Lee, Alicia
    Kim, Yun-Jeong
    Chang, Chungyu
    Ton-That, Hung
    Kim, Reuben
    Kim, Sangjae
    Park, No-Hee
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [29] The Anti-inflammatory Effect of GV1001 Mediated by the Downregulation of ENO1-induced Pro-inflammatory Cytokine Production
    Choi, Jiyea
    Kim, Hyemin
    Kim, Yejin
    Jang, Mirim
    Jeon, Jane
    Hwang, Young-il
    Shon, Won Jun
    Song, Yeong Wook
    Kang, Jae Seung
    Lee, Wang Jae
    IMMUNE NETWORK, 2015, 15 (06) : 291 - 303
  • [30] A phase III randomized trial of chemoimmunotherapy comprising gemcitabine and capecitabine with or without telomerase vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer.
    Middleton, Gary William
    Valle, Juan W.
    Wadsley, Jonathan
    Propper, David
    Coxon, Fareeda Y.
    Ross, Paul J.
    Madhusudan, Srinivasan
    Roques, Tom
    Cunningham, David
    Corrie, Philippa
    Greenhalf, William
    Shaw, Victoria
    Cox, Trevor F.
    Silcocks, Paul
    Nanson, Gemma
    Neoptolemos, John P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345